EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Coinfections in the lung: How viral infection creates a favorable environment for bacterial and fungal infections

Joshua J Obar, Kelly M Shepardson iD

PLOS Pathogens · 04.05.2023 · 19 (5) · e1011334

DOI: 10.1371/journal.ppat.1011334 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 04.05.2023. Verfasst von Joshua J Obar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Geisel School of Medicine at Dartmouth, Department of Microbiology & Immunology, Lebanon, New Hampshire, United States of America. Hauptthemen laut MEDLINE: Coinfection, Virus Diseases, Mycoses, Bacterial Infections. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While it is well established that secondary bacterial pneumonia plays a significant role in the morbidity and mortality of patients with severe respiratory viral infections, bacteria are not the only threat for these patients.Over the last decade, there has been a rise in the number of patients with severe respiratory viral infections acquiring secondary fungal infections, specifically with the filamentous mold Aspergillus fumigatus [1,2].Importantly, while secondary fungal infections occur less frequently than secondary bacterial pneumonias, they are associated with greater mortality [1].Because immune suppression is the major risk factor for acquiring fungal infections [3], severe respiratory viral infections may create a transient immune suppressed state allowing for these secondary infections to occur.Here, we discuss what we have learned about how antiviral host responses create a lung environment susceptible to bacterial infection and how this may translate into fungal susceptibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoinfectionVirus DiseasesMycosesBacterial InfectionsHumansLungBacteria

Autor:innen und Institutionen

  • Geisel School of Medicine at Dartmouth, Department of Microbiology & Immunology, Lebanon, New Hampshire, United States of America.
  • University of California, Merced, Department of Molecular and Cell Biology, Merced, California, United States of America.

ORCID-Profile: Kelly M Shepardson

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases
  • National Institute of General Medical Sciences
  • Francis Family Foundation

Zitieren

APA

Obar, J. J., & Shepardson, K. M. (2023). Coinfections in the lung: How viral infection creates a favorable environment for bacterial and fungal infections. PLOS Pathogens, 19(5), e1011334. https://doi.org/10.1371/journal.ppat.1011334

Vancouver

Obar JJ, Shepardson KM. Coinfections in the lung: How viral infection creates a favorable environment for bacterial and fungal infections. PLOS Pathogens. 2023;19(5):e1011334. doi:10.1371/journal.ppat.1011334

BibTeX
@article{Obar2023,
  author = {Obar, Joshua J and Shepardson, Kelly M},
  title = {Coinfections in the lung: How viral infection creates a favorable environment for bacterial and fungal infections},
  journal = {PLOS Pathogens},
  year = {2023},
  volume = {19},
  number = {5},
  pages = {e1011334},
  doi = {10.1371/journal.ppat.1011334}
}
Kostenlos starten →